SMN1 and Hepatic fibrosis: Human hepatic stellate cells (LX-2) were also treated with PFD and/or AGP <i>in vitro</i>.<h4>Results</h4>PFD and/or AGP ameliorates liver fibrosis and inflammation in the mice model of BA, as evidenced by significant downregulated in the accumulation of collagen fibers, hepatic fibrosis markers (<i>α</i>-SMA, collagen I, and collagen IV), and inflammatory markers (IL-1<i>β</i>, IL-6, and TNF-<i>α</i>).